DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

New look. Same commitment. Decision Resources Group becomes Clarivate. Read more here

Medtech teams have to make tough portfolio planning decisions while navigating a complex and fast-changing business environment, factoring in M&A activity, challenging pricing and purchasing conditions, mounting regulatory hurdles, and evolving customer dynamics.

Complicating this process, medtech market data can be particularly murky and difficult to validate.

Our data and market experts take out the guesswork, so you can focus on planning innovative solutions and driving portfolio success:

Increase confidence

in market models with accurate data and transparent methodologies

Maximize portfolio value

with expert guidance throughout the planning cycle

Edge out competitors

by staying on top of the latest market updates and emerging trends

Save time

with on-demand intelligence and prompt, customized follow up

What our clients say

"DRG’s team is one of the most collaborative I’ve ever worked with. They took the time to tailor the data sets to fit our business needs, and I would highly recommend working with them for market data and competitive intelligence needs."


Diagnostic Imaging Solutions Company

How we help


Market assessment

Always have a fresh, comprehensive and accurate view of your key markets

  • 10-year forecasts, regions driving growth, market dynamics and readiness, future trends
  • Intel on market opportunity and segmentation; procedures, patients and sites of care to inform market entry decisions
  • 80+ device markets and 50+ countries covered
  • Top-down, bottom-up methodology conducted by team of device market and data experts
    • Diverse set of data leveraged including industry and KOL interviews, hospital purchasing databases, claims and electronic health records, country-level epidemiology, and secondary sources
    • Complete hospital claims and ASC data coverage directly from CMS
    • Medtech market expertise to ensure correct mapping between procedure codes and device, procedure or disease categories

View our market assessment research


Patient segmentation and journey mapping

Identify opportunities to influence device choice and drive positive health outcomes

  • Integrated analysis provides a comprehensive view of the clinical, financial, attitudinal, and informational aspects of the journey – covering the “what” and “why” of key events
  • Leverages diverse data sets for a holistic view of disease progression and physician interactions, including claims and EHR, primary market research and social intelligence
  • Visibility into 300+ million patients (over 3 years), with the ability to link multiple aspects of the patient care experience

View our patient journey solutions


New device and solution design

Prioritize the solutions and features that will drive stakeholder purchasing and uptake decisions

  • Market experts and commercial strategists use quantitative and qualitative methodologies to assess the opportunity and market impact for new devices and technologies
  • New device concept and market receptivity testing to identify key factors among stakeholders
  • Competitor overview and white space analysis
  • Evidence, outcomes, and design recommendations


Next-generation iteration planning

Plan device enhancements that will increase market position and defend against new entrants

  • Quantitative and qualitative data-driven direction or validation on features to prioritize for product iteration
  • Provider and payer interviews identify the enhancements that will increase access and usage
  • Competitor overview and white space analysis


Obsolescence evaluation

Maximize portfolio revenue by optimizing your product launches and sunsetting

  • Robust assessment of portfolio, current and future competitors, and emerging market trends
  • Direction for optimal product launch and sunsetting timing and sequencing
  • Deep therapeutic knowledge, device expertise and on-demand market overviews differentiate us from other vendors – we’re already up to speed on your markets


Due diligence assessment

Increase confidence in your M&A decisions with robust opportunity assessments

  • Company target identification and evaluation to identify greatest opportunities for acquisition
  • Detailed review of companies to determine if they are poised for future growth from a product portfolio, organizational structure and synergy perspective
  • Assessment of target companies’ markets to understand future stakeholder product preferences, dynamics and access climate, and emerging competitors

How can we support your strategic portfolio planning?

Data and services

Our integrated data repository underpins all of our solutions

DRG Integrated Data Repository
  • Linking and integration capabilities for a comprehensive market view
  • Largest volume of patients and hospitals covered in the industry
  • Expansive coverage for geographies and insurance types
  • Fastest, freshest market data available


  • Visibility into 300+ million patients (over 3 years)
  • 2+ million healthcare providers
  • 98% of 750 U.S. payers, real-time insight into market changes
  • Submitted claims (837s) and remittance (835s)
  • Hospitals, physician offices, ASCs, pharmacies long-term care, and nursing

Purchase order data

  • 1,900 hospitals and ASCs
  • 3,000 U.S. manufacturers
  • 2+ million U.S. SKUs
  • SKUs mapped to device categories

Electronic health records

  • Visibility into 100+ million patients (over 3 years)
  • 90 million patients with overlapping EHRs and medical / pharmacy claims
  • Diagnoses, diagnostic tests, assessments, vaccines, vitals, Rx

Encounter level hospital device usage

  • U.S.: 6,800 hospitals, 2+ million providers
  • Complete hospital claims and ASC data coverage directly from CMS
  • Europe: 12,000 hospitals, 22 countries covered, facility-level data
  • Global: Research-driven understanding of volumes and brand usage

Healthcare provider affiliation directory

  • 6.5+ million affiliations
  • Affiliations among 3,200 health systems and 2+ million HCPs

On demand market overview

  • 50 countries
  • 12 therapeutic areas
  • 80 device markets

Full spectrum of commercialization intelligence solutions:

From data and insights to putting strategy in action


Learn more


  • Claims
  • Electronic health records
  • Purchase order data
  • Encounter-level hospital device usage data
  • Social intelligence
  • Epidemiology

Custom analytics & advisory

Learn more

Custom analytics & advisory

  • Real-world evidence
  • Market research
  • Custom data analysis
  • Advisory and consulting


Learn more


  • Therapy area training
  • Process document creation and training
  • Interactive market briefs for executives

Global coverage across 80+ device markets and 50+ countries

Why we're different

Data accuracy and diversity

The scale and depth of our patient claims, hospital purchase order and device usage data sets ensures that clients always have the most up-to-date and comprehensive market and customer intelligence driving key planning decisions.

Sean Messenger

Cardiovascular Expert

Decision Resources Group

Market expertise and advanced methodologies

Our team brings a wealth of deep market expertise across device areas and countries. For example, you need that grounding to map between procedure codes and device or disease categories, as well as to add context to the trends we’re seeing in the data.

Beyond the quality of our data sets, that’s really what sets us apart – we know these markets inside and out. Having a team of therapeutic experts, consultants, and data scientists who are transparent about the methodologies they’re deploying gives our clients confidence to act on the intelligence we’re providing.

April Chan-Tsui

Orthopedics Expert

Decision Resources Group

Collaborative partnerships

Our clients view us as true partners and extensions of their teams, not just as a data vendor who delivers solutions without support. We strive to truly understand our client’s business challenges and objectives so that we can assist with answering business questions quickly, create awareness around major shifts in the market, and provide proactive recommendations. We can only thrive as a company if we are helping our clients succeed!

Chris Leonard

Client Engagement Specialist

Decision Resources Group




4 Crazy Medtech Innovations Shaking Up the Treatment Landscape

View now



Renal Denervation: How Has The Space Evolved In The Past 5 Years?

View now


Blog post

4 Smart Tech-Based Solutions to Unique Healthcare Challenges in India and Japan

View now

Get started

Talk to us today about your strategic portfolio planning challenges

Related solutions

DRG data and experts support client decisions across the commercialization spectrum

Launch Strategy

Commercial Effectiveness

Market Access

Product Lifecycle Management

Medtech Overview